欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6313/001
药品名称Azacitidine EVER Pharma 25 mg/ml Pulver zur Herstellung einer Injektionssuspension
活性成分
    • azacitidine 100.0 mg
剂型Powder for suspension for injection
上市许可持有人EVER Valinject GmbH Oberburgau 3 4866 UNTERACH AM ATTERSEE Österreich
参考成员国 - 产品名称Germany (DE)
Azacitidine EVER Pharma 25 mg/ml Pulver zur Herstellung einer Injektionssuspension
互认成员国 - 产品名称
    • Denmark (DK)
    • Slovakia (SK)
      Azacitidín AqVida 25 mg/ml prášok na injekčnú suspenziu
    • Netherlands (NL)
      Azacitidine EVER Pharma 25 mg/ml poeder voor suspensie voor injectie
    • Ireland (IE)
    • Austria (AT)
      Azacitidin EVER Pharma 25 mg/ml Pulver zur Herstellung einer Injektionssuspension
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Azacitidine AqVida
    • Czechia (CZ)
      Azacitidine EVER Pharma 25 mg/ml prášek pro injekční suspenzi
许可日期2020/12/18
最近更新日期2024/02/01
药物ATC编码
    • L01BC07 azacitidine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase